Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04 ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The FDA has introduced a pilot program granting Commissioner’s National Priority Vouchers to three psychedelic therapy ...
The FDA will accelerate reviews for three psychedelic drug programs—two psilocybin therapies and one methylone treatment—cutting timelines from up to a year to as little as one to two months. The move ...
3don MSN
MAHA school lunch program seeing ‘impressive results’ tackling ultra-processed foods, says FDA head
Lunch ladies are getting a MAHA makeover. The Food and Drug Administration’s $17 million pilot program aimed at helping ...
The US Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have proposed a parallel ...
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...
On September 29, 2025, the U.S. Food and Drug Administration (FDA) announced the expansion of its Early Alert program to include all medical devices. This expansion builds on a pilot program that ...
The Food and Drug Administration Monday announced an initiative to encourage the use of RFID by drug companies. Phillips Industries’ new Cincinnati-area distribution center is now shipping aftermarket ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results